Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1147.7000 -37.40 (-3.16%)
NSE Jul 08, 2025 15:31 PM
Volume: 2.2M
 

1147.70
-3.16%
Geojit BNP Paribas
with multiple regulatory milestones lined up in the coming quarters. Execution of the pipeline delivery and expansion initiatives is expected to support long-term value creation. Therefore, we maintain our rating on the stock at BUY, with rolledforward target price of Rs. 1,348, based on 17.5x FY27x Adj. EPS....
Aurobindo Pharma Ltd. has an average target of 1461.67 from 9 brokers.
More from Aurobindo Pharma Ltd.
Recommended